founder Rodger Novak to step down as chairman; shares fall
** Shares of CRISPR Therapeutics CRSP.O fall 2.8% to
$49.65
** CRSP says its co-founder Rodger Novak to step down as the
company's president and chairman
** Says CEO Samarth Kulkarni will succeed Novak in the
additional role of chairman
** Up to last close, shares up 25.7% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Recent news on Crispr Therapeutics AG
See all newsBrief: CRISPR Therapeutics Announces Chief Financial Officer Transition
Swiss stocks - Factors to watch on August 4
Switzerland's CRISPR Therapeutics Q2 CASGEVY revenue jumps 151%, net loss narrows on FDA approval for expansion
Swiss stocks - Factors to watch on August 3
Gene-editing firm CRISPR steadies after boosted $550 mln convertible debt deal